Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James D Winkler

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Genomics|September 28, 2014
Recent advances in the evolutionary engineering of industrial biocatalystsJames D Winkler, Katy C Kao
Pharmacology & Therapeutics|February 23, 2017
Targeted protein degradation by PROTACsTaavi K Neklesa, James D Winkler, Craig M Crews
Metabolic Engineering Communications|June 21, 2021
The LASER database: Formalizing design rules for metabolic engineeringJames D Winkler, Andrea L Halweg-Edwards, Ryan T Gill
Mbio|November 16, 2017
Refactoring the Genetic Code for Increased EvolvabilityGur Pines, James D Winkler, Assaf Pines, et al.
Metabolic Engineering Communications|February 23, 2018
Quantifying complexity in metabolic engineering using the LASER databaseJames D Winkler, Andrea L Halweg-Edwards, Ryan T Gill
Biochimica Et Biophysica Acta|December 30, 2006
Clinical experience of MEK inhibitors in cancer therapyDing Wang, Scott A Boerner, James D Winkler, et al.
ACS Synthetic Biology|April 10, 2015
Bacterial Recombineering: Genome Engineering via Phage-Based Homologous RecombinationGur Pines, Emily F Freed, James D Winkler, et al.
Applied and Environmental Microbiology|April 15, 2014
Evolved osmotolerant Escherichia coli mutants frequently exhibit defective N-acetylglucosamine catabolism and point mutations in cell shape-regulating protein MreBJames D Winkler, Carlos Garcia, Michelle Olson, et al.
Current Topics in Medicinal Chemistry|April 28, 2005
Progress towards therapeutic small molecule MEK inhibitors for use in cancer therapyEli M Wallace, Joseph P Lyssikatos, Tammie Yeh, et al.
ACS Synthetic Biology|October 12, 2017
The Tolerome: A Database of Transcriptome-Level Contributions to Diverse Escherichia coli Resistance and Tolerance PhenotypesKeesha E Erickson, James D Winkler, Danh T Nguyen, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Genomics|September 28, 2014
Recent advances in the evolutionary engineering of industrial biocatalystsJames D Winkler, Katy C Kao
Pharmacology & Therapeutics|February 23, 2017
Targeted protein degradation by PROTACsTaavi K Neklesa, James D Winkler, Craig M Crews
Metabolic Engineering Communications|June 21, 2021
The LASER database: Formalizing design rules for metabolic engineeringJames D Winkler, Andrea L Halweg-Edwards, Ryan T Gill
Mbio|November 16, 2017
Refactoring the Genetic Code for Increased EvolvabilityGur Pines, James D Winkler, Assaf Pines, et al.
Metabolic Engineering Communications|February 23, 2018
Quantifying complexity in metabolic engineering using the LASER databaseJames D Winkler, Andrea L Halweg-Edwards, Ryan T Gill
Biochimica Et Biophysica Acta|December 30, 2006
Clinical experience of MEK inhibitors in cancer therapyDing Wang, Scott A Boerner, James D Winkler, et al.
ACS Synthetic Biology|April 10, 2015
Bacterial Recombineering: Genome Engineering via Phage-Based Homologous RecombinationGur Pines, Emily F Freed, James D Winkler, et al.
Applied and Environmental Microbiology|April 15, 2014
Evolved osmotolerant Escherichia coli mutants frequently exhibit defective N-acetylglucosamine catabolism and point mutations in cell shape-regulating protein MreBJames D Winkler, Carlos Garcia, Michelle Olson, et al.
Current Topics in Medicinal Chemistry|April 28, 2005
Progress towards therapeutic small molecule MEK inhibitors for use in cancer therapyEli M Wallace, Joseph P Lyssikatos, Tammie Yeh, et al.
ACS Synthetic Biology|October 12, 2017
The Tolerome: A Database of Transcriptome-Level Contributions to Diverse Escherichia coli Resistance and Tolerance PhenotypesKeesha E Erickson, James D Winkler, Danh T Nguyen, et al.
Pageof 3